Organon Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Oss Netherlands (1923)
Status: Acquired by Schering-Plough (2007) → now Merck (2009)

Organization Overview

First Clinical Trial
2000
NCT01062867
First Marketed Drug
1939
heparin (liquaemin)
First NDA Approval
1939
heparin (liquaemin)
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ORGANON | Organon GmbH (former name) | ORGANON SUB MERCK | Organon Teknika | ORGANON USA INC | Zwanenberg Organon